Quick Answer
Lunai Bioworks Inc. reported Research And Development Expense of $537.4 thousand for the year ending 2025.
- Lunai Bioworks Inc. showed a decrease of -80.2% in Research And Development Expense from 2024 to 2025.
- This data is from Lunai Bioworks Inc.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $151.8 thousand | Q3 2015: $101.8 thousand | Q4 2015: $277.6 thousand | Q1 2016: $235.9 thousand | Q3 2016: $17.1 thousand | Q4 2016: $13.8 thousand | Q1 2017: $16.3 thousand | Q3 2017: $153.7 thousand | Q4 2017: $220.0 thousand | Q1 2018: $137.9 thousand | Q3 2018: $493.6 thousand | Q4 2018: $789.0 thousand | Q1 2019: $730.3 thousand | Q3 2019: $520.2 thousand | Q4 2019: $561.5 thousand | Q1 2020: $2.31 million | Q3 2020: $1.05 million | Q4 2020: $1.33 million | Q1 2021: $1.12 million | Q3 2021: $3.06 million | Q4 2021: $2.34 million | Q1 2022: $1.21 million | Q3 2022: $2.61 million | Q4 2022: $326.0 thousand | Q1 2023: $239.1 thousand | Q3 2023: $566.6 thousand | Q4 2023: $620.5 thousand | Q1 2024: $1.09 million | Q3 2024: $390.2 thousand | Q4 2024: $161.1 thousand | Q3 2025: $24.4 thousand | Q4 2025: $45.9 thousand.
- Over the full 10 years of available data (2016 to 2025), Lunai Bioworks Inc.'s Research And Development Expense has declined by 33.2%.
- Historical annual values: Fiscal year 2025: $537.4 thousand | Fiscal year 2024: $2.71 million | Fiscal year 2023: $4.17 million | Fiscal year 2022: $8.37 million | Fiscal year 2021: $15.72 million | Fiscal year 2020: $4.69 million | Fiscal year 2019: $2.50 million | Fiscal year 2018: $617.0 thousand | Fiscal year 2017: $62.8 thousand | Fiscal year 2016: $804.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: